Feedback / Questions
Nebulized Ampion (aspartyl-alanyl diketopiperazine) - Ampio
https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-receives-approval-to-expand-enrollment-of-its-ap-019-phase-ii-study-to-india-301312190.html
Jun 15, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next